A meta-analysis showed that PD-1/PD-L1 inhibitor combined with chemotherapy increased the risk of full-grade arrhythmia and hypertension; especially a PD-L1 inhibitor combined with chemotherapy caused more arrhythmias (22). The gene discussed is CD274; the disease is cardiac arrhythmia.